Previous Issues

2017

10/12/2017 #235 Global Investors Come to NYC in Search of New Technology Assets

10/05/2017 #234 Biotech Week Boston – One Person’s Opinion

09/28/2017 #233 RESI Boston 2017 Innovation Challenge – Winners Announced

09/21/2017 #232 Just Released: Redefining Early Stage Investments (RESI) Conference Program Guide

09/14/2017 #231 McDermott Will & Emery Joins RESI NYC As a Title Sponsor 

09/07/2017 #230 RESI Boston vs Other Conferences

08/31/2017 #229 Top 40 RESI Innovators Announced – And How To Find Life In The Valley Of Death

08/24/2017 #228 Next Phase Interview: NCI Program Director Todd Haim Explains How RESI Boston Became A Showcase For NIH SBIR Grantees

08/17/2017 #227 Get Ready, RESI Partnering Opens Monday, August 21st – New Premier Partnering Plus Is On The Docket

08/10/2017 #226: WuXi AppTec Signs on as a RESI Title Sponsor for Boston, NYC and San Francisco Conferences

08/03/2017 #225: RESI Boston: Insight from China Strategic Partners on Cross-Border Opportunities

07/27/2017 #224: RESI Boston: Venture Philanthropy Investors Share Their Perspective on Investing for Impact

07/20/2017 #223: Growth of An Early Stage Phenomenon: Four Years of RESI in Boston

07/13/2017 #222: Must See Video—CEOs Explain Sourcing Family Offices, Working Your Pipeline and Cost of Campaigns – Tales from the Road at RESI

07/06/2017 #221: RESI Boston 2017: Agenda Announced

06/29/2017 #220: An Executive Summary, A PowerPoint Prezo and A Website – You Better Go for It! 

06/22/2017 #219: RESI San Diego 2017 Innovation Challenge – Winners Announced

06/15/2017 #218: There’s Only One Choice If You are in San Diego on June 19th

06/08/2017 #217: RESI San Diego: Check Out the Program Guide Now

06/01/2017 #216: RESI Innovation Challenge: LSN’s Scientific Review Team Selects 30 Top Life Science Startups

05/25/2017 #215: Life Science Nation Ecosystem – A Matching Platform for Buyers and Sellers 

05/18/2017 #214: RESI Partnering Opens Monday 5/22 – The Early Entrepreneur Gets the Meetings

05/11/2017 #213: A Winning Formula for Raising Capital

05/04/2017 #212: Finding, Vetting and Profiling Assets – LSN’s Unique Sourcing & Ranking Service (SRS)

04/27/2017 #211: Boston Innovation Capital Celebrates Our One Year Anniversary

04/20/2017 #210: RESI San Diego – Early Bird Rate Ends Tomorrow

04/13/2017 #209: Redefining Early Stage Investments (RESI) Conference on MaRS Report

04/06/2017 #208: RESI on MaRS Innovation Challenge – Winners Announced

03/30/2017 #207: Identifying Strategic Partners in Asia 

03/23/2017 #206: RESI on MaRS 2017 Program Guide

03/16/2017 #205: Life Science Nation’s RESI Conference – The Sweet Spot 

03/09/2017 #204: 30 Leading Life Science Startups Compete in Innovation Challenge at The Redefining Early Stage Investments (RESI) Conference at MaRS

03/02/2017 #203: Where’s the “Third Coast” in 2017? Comparing Emerging Life Science Hubs in NYC and Toronto 

02/23/2017 #202: Canvassing Globally, Keep Your Options Open – Preclinical Funding Can Morph to a Licensing Deal 

02/16/2017 #201: Caveat Emptor When Signing Up for Family Office Conferences 

02/09/2017 #200: RESI on MaRS: Full Agenda Announced

02/02/2017 #199: US Investors Look to Toronto to Scout Health Innovations

01/26/2017 #198: Canada’s Life Science Landscape

01/19/2017 #197: RESI Lands on MaRS Again in 2017

01/12/2017 #196: RESI Innovators Shine in San Francisco – Winners Announced

01/05/2017 #195: RESI San Francisco 2017 Program Guide

2016

12/29/2016 #194: 2016 Highlights: A Look Back at Next Phase’s Top 10 Articles

12/22/2016 #193: HAPPY HOLIDAYS from Life Science Nation

12/15/2016 #192: Calling All Capital Raising CEOs

12/08/2016 #191: RESI @ JPM Will Soon Be SOLD OUT Redefining Early Stage Investments Conference at 75% Capacity with Only a Month to Go – Carpe Diem

12/01/2016 #190: RESI Partnering Opens Soon: Look Who You Can Meet

11/24/2016 #189: Happy Thanksgiving and Warm Wishes from LSN

11/17/2016 #188: When You’re Raising Capital, You Can’t Prescribe Reality

11/10/2016 #187: How to Use Your Pitch Deck to Pique Investor Interest

11/03/2016 #186: Is the Early Stage Opportunistic Investment Strategy Broken?

10/27/2016 #185: It’s A Numbers Game: Why Some Folks Book Lots of Partnering Meetings and Others Don’t @ Investor Conferences

10/20/2016 #184: The Investors You’ll Meet at RESI San Francisco

10/13/2016 #183: Short-Term Investors in Long-Term Development: Matching an Investor’s Time Horizon

10/06/2016 #182: Behind the Curtain of RESI Partnering

09/28/2016 #181: Heading to JPM? Read The RESI SF Agenda

09/22/2016 #180: Big Data, Digital Medicine, and A View of the Future at RESI X

09/15/2016 #179: RESI SF 2017 Will Definitely Sell Out! Register Early Bird

09/08/2016 #178: Redefining Early Stage Investments Conference Series – Boston 2016 Program Guide Announced

09/01/2016 #177: RESI Boston 2016 Agenda Announced

08/25/2016 #176: Partnership Building: First Step of a Successful Asia Strategy for Your Startup

08/18/2016 #175: Compelling New Technology Startups Selected, RESI X Innovation Challenge

08/11/2016 #174: RESI Boston Panel Announcement: Early Stage Therapeutics Investors

08/04/2016 #173: RESI Boston Panel Announcement: Medtech Strategic Firms Partnering for Innovation

07/28/2016 #172: Drug Development: What Does It Cost, and Who Has The Capital?

07/21/2016 #171: Top Tier Early Stage Investors to Attend 10th RESI Conference in Boston on September 13th

07/14/2016 #170: 10th RESI Marks Milestone with Asia-North America Investor Track

07/07/2016 #169: Semiconductors and Cells: Innovation and Investment In Cell Sorting Technologies

06/30/2016 #168: RESI Boston 2016: Come to the Hub of Life Sciences to Meet 300+ Investors

06/16/2016 #167: RESI on MaRS Program Guide Announced

06/09/2016 #166: 30 Startups Will Rock MaRS HealthKick Innovation Challenge

06/02/2016 #165: Early Stage Life Science Investors Make RESI on MaRS a Must Attend Event (Scroll Down to View Investor Attendees)

05/26/2016 #164: Emerging Opportunities in Medical Robotics

05/19/2016 #163: Put The Spotlight On Your Company in the RESI Innovation Challenge

05/12/2016 #162The Journey of the Executive Summary and the PowerPoint Pitch Deck

05/05/2016 #161: Look Who’s Coming To RESI on MaRS

04/28/2016 #160: From Lab Bench to Bedside in Record Time: How Industry, Academia, Healthcare Providers Fuel Toronto’s R&D

04/21/2016 #159: Corporate Partnerships On The Rise: The Toronto Opportunity

04/14/2016 #158: RESI does Toronto, where health means business. Lots of it.

04/07/2016 #157: RESI@TMCx – Program Guide

03/31/2016 #156: Redefining Early Stage Investments (RESI) Conference…Get On Board The Investor Train

03/24/2016 #155:Top Takeaways for Pitching from the WIB, JLABS, and J&J Innovation Lobster Pot

03/17/2016 #154: RESI@TMCx Innovation Challenge: Participating Startups Announced

03/10/2016 #153: How Massachusetts Wins the War for Global Talent

03/03/2016 #152: Nature BioEntrepreneur Features LSN: Aligning Needs

02/25/16 #151: Behind the Curtain: Building an Investor-Centric Partnering Event

02/18/2016 #150: A Two Pronged Approach to Sourcing Life Science Technology

02/11/2016 #149: RESI@TMCx: Agenda Announced

02/04/2016 #148: Fundraising Best Practices at the Freemind Group’s Non-Dilutive Funding Summit

01/28/2016 #147:Fundraising Season 2016: Making the Most of January – June

01/21/2016 #146: RESI@TMCx Take 2: LSN , JLABS and TMCx Team-up Again for Early Stage Investor Event

01/07/2016 #145: RESI@JPM – The Good News, And The Bad News

2015

12/31/2015 #144: Licensing Deals in Year 2015: Early Stage Endocrine Assets Scored Big

12/24/2015 #143: Happy Holidays from Life Science Nation

12/17/2015 #142: RESI Innovation Challenge: Participating Startups Announced

12/10/2015 #141: How the Affordable Care Act Affects Investor Mandates

12/03/2015 #140: 4 Tips on How to Get the Most Out of Partnering

11/25/2015 #139: LSN Wishes You A Happy Thanksgiving And A Fruitful Fundraising Campaign

11/19/2015 #138: Pitching to a Foundation? Be Prepared for These Issues

11/12/2015 #137: Rising Opportunities in Precision Medicine

11/05/2015 #136: Early Stage Global Investors Converging on RESI@JPM

10/29/2015 #135: Medtech Family Offices Talk Trends and Evaluation Criteria

10/22/2015 #134: To Raise Capital, Go Outbound Without Assumptions

10/15/2015 #133: Life Science CVC Panelists Discuss Investment Trends

10/08/2015 #132: Common Pitfalls In Managing A Therapeutic Asset

10/01/2015 #131: September Mandate Roundup: Asian Based Investors Continue to Show Interest in Global Technologies

09/24/2015 #130: Seeking Capital? Learn A Little Sales (There I Said It)

09/17/2015 #129: RESI Innovation Challenge Winners Announced

09/10/2015 #128: It’s Not Too Late to Register – Check out the RESI Program Guide

09/03/2015 #127: How to Write a Compelling Partnering Message

08/27/2015 #126: What Does It Take to Get a Meeting: The Targeted Outreach Curve

08/20/2015 #125: Innovation In Spotlight at RESI

08/13/2015 #124: Breakdown of Investors You Can Meet at RESI Boston

08/06/2015 #123: Using CRM to Build A Data-Driven, Transparent Fundraising Campaign

07/30/2015 #122: Winning Your Next Stage Investment-One Competition at a Time

07/23/2015 #121: Therapeutic Financing Rounds in 2015: Gene Therapy Outpaces Antibodies in Early Stage Investment

07/16/2015 #120: RESI Innovation Challenge Now Accepting Applications

07/09/2015 #119: Keeping It Fresh: The Importance of Up-to-Date Investor Data

07/02/2015 #118: Back to Boston and Bigger than Ever: RESI Conference on September 16th

06/25/2015 #117: Family Offices and Walled Gardens

06/18/2015 #116: RESI Wraps Up in Houston and Heads Back to Boston

06/11/2015 #115: Winners Announced From Latest RESI Innovation Challenge

06/04/2015 #114: LSN Summer Chapter Series: Issue #2

05/28/2015 #113: An LSN Summer Chapter Series 

05/21/2015 #112: Getting the Most from a 30-Minute Investor Meeting

05/14/2015 #111: How Do Investors Assess a Management Team?

05/07/2015 #110: New Models Emerge to Aid Scientist-Entrepreneurs Journey from Bench to Bedside

04/30/2015 #109: If You Build It, They Will Come!

04/23/2015 #108: Things to Consider in Building Big Pharma Partnerships

04/16/2015 #107Are You a Fit for the Greater China Market?

04/09/2015 #106JLABS Collaborates with LSN and TMCx for Early Stage Investor Event

04/02/2015 #105Researching Life Science Investors: Webinar Now Available

03/26/2015 #1046 Takeaways from Women In Bio Shark Tank

03/19/2015 #103Calling All Innovators! RESI Innovation Challenge: Applications Now Open

03/12/2015 #102: The Magnificent Seven-Fundraising Challenges Facing Life Science Entrepreneurs

03/05/2015 #101: Building Your Brand: The Importance of a Consistent Message

02/26/2015 #100: A Look Back at Our Top Five Articles

02/19/2015 #99: Texas Medical Center to Host Redefining Early Stage Investments Conference

02/12/2015 #98: LSN Fundraising Boot Camp at the 10th Non-Dilutive Funding Summit

02/05/2015 #97: Asia-Based Investors Are Increasingly Seeking Global Innovation

01/29/2015 #96: The Life Science Venture Philanthropy Landscape

01/22/2015 #95: RESI 4 San Francisco: Compelling Connections Created, Dialogues Begun, the Game’s Afoot

01/08/2015 #94: RESI 4 Is Approaching – Check Out the Program Guide

2014

12/18/2014 #93: Year-End Roundup: Investor Mandates

12/11/2014 #92: Do You Have the Right Investor List?

12/04/2014 #91: Partnering Based on Fit!

11/27/2014 #90: Life Science Nation and FreeMind Group Align In San Francisco for Early Stage Fundraising Executives

11/20/2014 #89: 11 Tips for Creating a Successful Pitch Deck

11/13/2014 #88: Looking For Capital? The Top Three Questions For Fundraising CEOs Before You Start

11/06/2014 #87: 109 Investors from 20 Countries- October Mandate Roundup

10/30/2014 #86: 10 Steps to a Life Science Fundraising Campaign

10/23/2014 #85: Family Offices Investing in Early Stage Medtech: RESI 4 Announces First Panel

10/16/2014 #84: Scientist-Entrepreneurs and Investors Made Compelling Connections at RESI 3

10/09/2014 #83: Successful Life Science Entrepreneurs Tell Their Tales from the Road

10/02/2014 #82: Major Corporate Venture Funds Discuss Early Stage Investing

09/26/2014 #81: Video: Five Family Offices Discuss Life Science Investment at RESI 3

09/19/2014 #80: RESI Innovation Challenge: Who Knocked it Out of the Park at the Home of the Boston Red Sox? 

09/11/2014 #79: If You’re Serious About Raising Capital, Check Out The RESI Program

09/04/2014 #78: Family Offices Investing Direct

08/28/2014 #77: Live Investor Leads Sent to Your Mailbox

08/21/2014 #76: LSN Announces RESI Partnering Platform

08/14/2014 #75: Preclinical and Phase I Investors Leading the Charge at RESI

08/07/2014 #74: The Place to Meet Early Stage Investors

07/31/2014 #73: July Roundup: 76 Mandates

07/24/2014 #72: Virtual Pharma Partners: Guiding Assets to Commercialization  

07/17/2014 #71: Mapping Out the Early Stage Fundraising Dilemma

07/10/2014 #70: LSN Garners 56 New Investor Mandates in June 2014

07/03/2014 #69: East Meets West

06/26/2014 #68: The Life Science Executive’s Fundraising Manifesto:Why I Wrote This Book 

06/19/2014 #67: LSN Announces Life Science Fundraising Accelerator

06/12/2014 #66: LSN Releases Book: The Life Science Executive’s Fundraising Manifesto

06/05/2014 #65: Investors Want Therapeutics, Devices and Diagnostics – LSN’s 20 Most Recent Mandates

05/29/2014 #64: It’s Raining Investors Seeking Early Stage

05/22/2014 #63: The Road to Commercialization: Do Life Science Incubators Deliver on Their Promise?

05/15/2014 #62: Save the Date for the Next RESI Conference: September 17, 2014

05/08/2014 #61: Filtering the Noise: How Life Science Investors Manage Prospects

05/01/2014 #60: Do Traditional Marketing Techniques Apply to Life Sciences?

04/24/2014 #59: The Importance of Single-Asset Focus

04/17/2014 #58: Top 5 Indications For Non-VC Early Stage Investors

04/10/2014 #57: Early Stage Investors Go Global

04/03/2014 #56: Stars Align for Rare Disease Investment

03/27/2014 #55: Women CEOs Lead the Day at the RESI Innovation Challenge

03/20/2014 #54: Life Science Investors Step Into the Spotlight

02/21/2014 #53: Getting Non-fits Off the Plate

02/06/2014 #52: Formulating the Introductory Email to Potential Investors

01/30/2014 #51: A Deep Dive: LSN Family Office Investor Mandates

01/23/2014 #50:  See It for Yourself! LSN Investor Database Demo

01/09/2014 #49: LSN Published in Nature Bioentrepreneur: “Beyond Venture Capital”

2013

12/19/2013 #48: The Market Strata for Early Stage Innovation

12/12/2013 #47: Adapting Your Start-up to the Investor Mindset

12/05/2013 #46: CRO Trends in 2014

11/21/2013 #45: LSN Announces RESI II

11/14/2013 #44: LSN Database Feature: Non-VC Interest in Early Stage Biotech

11/07/2013 #43: Next Generation Philanthropy, and How to make it Happen

11/01/2013 #42: Funding from the Crowd

10/25/2013 #41: Phone Canvassing Issue

10/17/2013 #40: Email Marketing Issue

10/10/2013 #39: Validating the New Investment Dynamic Between the US and EU

10/03/2013 #38: Creating a Dialogue with Life Science Investors

09/26/2013 #37: Hello World…ABC Life Science Company is Raising Capital!

09/20/2013 #36: RESI Conference Recap: A Great Day For Early Stage Life Sciences

09/12/2013 #35: The History of the RESI Conference

08/30/2013 #34: The Chasm of Skepticism

08/15/2013 #33: The Last Three Feet: Vetting and Grooming the Scientists for Success

08/09/2013 #32: Gorillas at the Table: Corporate Venture Capital

08/01/2013 #31: Crowdfunding: The Good, the Bad, & the Ugly

07/25/2013 #30: Lines Blurring between VC, PE and Hedge Funds in Life Science Investing

07/19/2013 #29: 100+ Early Stage Life Science Investors Converge on Boston

07/11/2013 #28: Electronic Patient Records’ Impact on Clinical Testing

06/27/2013 #27: Winds of Change in the CRO Space

06/20/2013 #26: NIH Resurrecting Big Pharma Castoffs

06/13/2013 #25: The Importance of Investor Fit

06/06/2013 #24: Redefining Early Stage Investments

05/23/2013 #23: Investment Banks – Family Office Direct Investment Trend

05/17/2013 #22: Crowdfunding and the Life Science Arena

05/09/2013 #21: Science and Investing in an Overhyped World

05/02/2013 #20: The Emperor’s New Clothes

04/25/2013 #19: Big Device Firms Focusing on Early Stage Opportunities

04/18/2013 #18: Elucidating the Timeline to Capital

04/11/2013 #17: Venture Philanthropy Providing Capital for Early Stage Science

04/04/2013 #16: Mapping Your Fundraising Strategy

03/28/2013 #15: The Mantra and Myths of Capital Efficiency

03/22/2013 #14: Life Science Players Adopt a Pervasive Global Approach

03/14/2013 #13: Personalized Medicine Trend Spurs Investments in Diagnostics

03/07/2013 #12: CRO Trends in 2013

02/27/2013 #11: How to Easily Select Investors that May Be a Fit

02/21/2013 #10: Outsourcing your Fundraising Efforts: The Conundrum for Life Science CEOs

02/12/2013 #9: Epigenetics, Antibodies & Orphan Therapeutics: Leading Biotech Licensing Trends in 2013

02/05/2013 #8: The Straightest Line to Commercialization

01/29/2013 #7: Leveraging Outbound Marketing for Fundraising Campaigns

01/22/2013 #6: Validating the Family Office Life Science Investment Strategy

01/15/2013 #5: Branding, Messaging & Identifying Investor Targets

01/08/2013 #4: What’s New in the “Valley of Death”?

2012

12/18/2012 #3: The Genealogy of Family Offices

12/11/2013 #2: Family Offices: The New VCs

12/05/2013 #1: Life Science Nation Newsletter

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: